HMGB1 and recessive dystrophic epidermolysis bullosa: Observed decreases in HMGB1 serum levels during MSC treatment were more pronounced in the patients with higher baseline levels (Figure 6), which was also seen in a recent study by Rashidghamat et al. (31) of i.v. infusions of BM-derived MSCs to treat RDEB.